Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE 3 ( March, 2022 ) > List of Articles


Corticosteroids for Non-severe COVID-19: Primum Non Nocere

Inderpaul S Sehgal, Ashutosh N Aggarwal, Ritesh Agarwal

Keywords : Acute respiratory distress syndrome, Corticosteroids, COVID-19

Citation Information : Sehgal IS, Aggarwal AN, Agarwal R. Corticosteroids for Non-severe COVID-19: Primum Non Nocere. Indian J Crit Care Med 2022; 26 (3):403-404.

DOI: 10.5005/jp-journals-10071-24138

License: CC BY-NC 4.0

Published Online: 30-03-2022

Copyright Statement:  Copyright © 2022; The Author(s).


  1. Nasa P, Chaudhry D, Govil D, Daga MK, Jain R, Chhallani AA, et al. Expert consensus statements on the use of corticosteroids in non-severe COVID-19. Indian J Crit Care Med 2021;25(11):1280–1285. DOI: 10.5005/jp-journals-10071-23923.
  2. Rochwerg B, Agarwal A, Siemieniuk RA, Agoritsas T, Lamontagne F, Askie L, et al. A living WHO guideline on drugs for covid-19. British Medical Journal 2020;370:m3379. DOI: 10.1136/bmj.m3379.
  3. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693–704. DOI: 10.1056/NEJMoa2021436.
  4. Garg M, Prabhakar N, Bhalla AS, Irodi A, Sehgal I, Debi U, et al. Computed tomography chest in COVID-19: when and why? Indian J Med Res 2021;153(1):86–92. DOI: 10.4103/ijmr.IJMR_3669_20.
  5. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 2021;186(2):289–298. DOI: 10.1007/s11046-021-00528-2.
  6. Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia 2021;186(6):739–754. DOI: 10.1007/s11046-021-00584-8.
  7. Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis 2021;27(9): 2349–2359. DOI: 10.3201/eid2709.210934.
  8. Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. British Medical Journal 2017;357:j1415. DOI: 10.1136/bmj.j1415.
  9. Shuto H, Komiya K, Yamasue M, Uchida S, Ogura T, Mukae H, et al. A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19. Sci Rep 2020;10(1):20935. DOI: 10.1038/s41598-020-78054-2.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.